RE:RE:Confirming newsIt is a good news for the regular COVID, but the Brasil variant is probably different. So saliva test was probably performing below 80%, instead of over 80% as required. This is why Rob said:
We will now test AcuVid™ with the known variants to validate its effectiveness and, if necessary, optimize the test to detect these variants."
They still have work to do. Don't forget that SONA will probably be in the same boat, as they probably have tested againt the regular COVID without variant